Table 1 Demographic data of PD patients with olfactory dysfunction and PD patients without olfactory dysfunction
PD patients with olfactory dysfunction | PD patients without olfactory dysfunction | p value | |
|---|---|---|---|
(N = 56) | (N = 44) | ||
Age, mean (SD) | 68.29 (7.64) | 67.09 (8.35) | 0.463 |
Gender, female, N (%) | 29 (51.79) | 19 (43.18) | 0.393 |
Body mass index, mean (SD) | 22.19 (2.11) | 22.42 (2.46) | 0.631 |
Duration, mean (SD) | 7.86 (4.40) | 6.86 (5.29) | 0.319 |
Hoehn – Yahr Staging, N (%) | |||
1.0 | 9 (16.07) | 14 (31.82) | 0.242 |
1.5 | 7 (12.50) | 7 (15.91) | |
2.0 | 18 (32.14) | 11 (25.00) | |
2.5 | 13 (23.21) | 5 (11.36) | |
3.0 | 5 (8.93) | 6 (13.64) | |
4.0 | 4 (7.14) | 1 (2.27) | |
5.0 | 0 (0) | 0 (0) | |
SS-16, mean (SD) | 2.54 (1.56) | 11.93 (1.11) | < 0.001 |
HARS, mean (SD) | 1.55 (1.04) | 1.39 (1.24) | 0.476 |
HDRS, mean (SD) | 1.52 (1.19) | 1.32 (1.20) | 0.409 |
SCOPA – AUT, mean (SD)* | 14.73 (9.05) | 9.75 (7.37) | 0.008 |
Gastrointestinal symptoms* | 5.00 (4.11) | 3.07 (3.00) | 0.024 |
Urinary symptoms* | 5.38 (4.49) | 2.89 (3.80) | 0.008 |
Cardiovascular symptoms* | 0.70 (1.11) | 0.32 (0.86) | 0.076 |
Skin symptoms* | 2.70 (2.48) | 2.66 (2.81) | 0.793 |
Sexual symptoms* | 0.50 (1.54) | 0.55 (1.45) | 0.804 |
Drug usage* | 0.46 (0.66) | 0.50 (1.68) | 0.783 |